- Home
- » e-Newsletters
Antipsychotics increase risk of death in Alzheimer's residents
LTC Liability Monitor, November 10, 2005
Newer antipsychotic medications pose an increased risk of death in elderly dementia residents, according to a study from Johns Hopkins Medical Institutions. Johns-Hopkins psychiatrists concluded that so-called second generation antipsychotic medications-used to treat aggressive or psychotic behavior-spur a small increase in the risk of death to dementia-afflicted residents due to harmful side effects.
Second generation antipsychotics should not be used when alternative treatments, such as behavior interventions or antidepressants, are available, the psychiatrists advised. The study was published in the October 19 issue of the Journal of the American Medical Association.
Most Popular
- Articles
-
- HIPAA Q&A: Flu shot requirement for hospital employees
- Running an effective peer review committee meeting
- HealthDataInsights posts new issues for medical necessity claims
- Sneak Peek: Effort underway to establish caseload benchmarks
- Q/A: Coding for telescopic intraocular lens
- New FAQ posted on storing laryngoscope blades
- Tip: Perform your own internal investigation prior to government audit
- HIPAA 5010 deadline extended, but threat remains, says AMA
- HHS task force: Consider privacy, security with text messages
- What does case-mix index mean to you?
- E-mailed
-
- Running an effective peer review committee meeting
- HIPAA Q&A: Flu shot requirement for hospital employees
- HHS task force: Consider privacy, security with text messages
- What does case-mix index mean to you?
- Q/A: Coding for telescopic intraocular lens
- Q/A: Correct use of modifier -PT
- Tip: Correctly code bilateral pain management procedures
- "Wall fountains" may be spreading Legionnaires to patients, visitors
- 2012 CPT code changes for ASCs: Shoulder and knee scopes and pain management
- COT basics to best
- Searched